Skip to content
value.today

Abbott Laboratories vs Surmodics, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Abbott Laboratories is the larger company by market value: $181.1 B against $487 M for Surmodics, Inc., 372 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for Surmodics, Inc.). Surmodics, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $105 M for Surmodics, Inc. in the year to September 2021.
  • Abbott Laboratories earned more: net income of $6.5 B against $4 M for Surmodics, Inc.
  • Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against 3.8% for Surmodics, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

039791181582020202120222023202420252026Abbott Laboratories 119Surmodics, Inc. 88

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$11B$22B$33B$44B201720182019202020212022202320242025Abbott Laboratories $44B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbott Laboratories
ABT · #117 in the world
Surmodics, Inc.
SRDX
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices
Founded18881979
Size
Market cap$181.1 B$487 M*
Revenue$44.3 B$105 M
Net income$6.5 B▲ best$4 M
Employees115,000—
Valuation
P/E ratio38.5×—
Price to sales3.8×—
Price to book3.5×—
Free cash flow yield4.1%—
Profitability
Gross margin56.4%—
Operating margin18.2%—
Net margin14.7%—
Return on equity13.1%—
Return on invested capital11.2%—
Growth
Revenue growth5.7%—
Revenue growth, 3 years a year0.5%—
Earnings per share growth-51.3%—
Financial strength
Debt to equity0.3×—
Cash
Free cash flow margin16.7%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.8%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Abbott Laboratories or Surmodics, Inc.?

Abbott Laboratories is the larger company by market value: $181.1 B against $487 M for Surmodics, Inc., 372 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for Surmodics, Inc.). Surmodics, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Abbott Laboratories or Surmodics, Inc.?

Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $105 M for Surmodics, Inc. in the year to September 2021. Abbott Laboratories earned more: net income of $6.5 B against $4 M for Surmodics, Inc.

Which is more profitable, Abbott Laboratories or Surmodics, Inc.?

Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against 3.8% for Surmodics, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.